Proteon Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Proteon Therapeutics Inc
TickerTARA
CIK #0001359931
CUSIP74365U107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address200 West Street, Waltham, MA 02451
Source [EDGAR]
CIK Filing 2011 - 2025
[0001359931] 10-K
[0001359931] 10-Q
[0001359931] 3
[0001359931] 4
[0001359931] 5
[0001359931] 8-K
[0001359931] D
[0001359931] SC 13D
[0001359931] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Protara Therapeutics Inc [2025-07-17] 0.0
Janus Henderson Group PLC Protara Therapeutics Inc [2025-02-14] 0.0
Adage Capital Management LP Protara Therapeutics Inc [2025-02-12] 0.0
Velan Capital Investment Management LP Protara Therapeutics Inc [2024-12-17] 5.9
Opaleye Management Inc Protara Therapeutics Inc [2024-11-18] 8.15
Woodline Partners LP Protara Therapeutics Inc [2024-11-14] 7.4
RA Capital Management LP Protara Therapeutics Inc [2024-04-25] 0.99
Citadel Advisors LLC Protara Therapeutics Inc [2024-04-22] 5.7
CVI Investments Inc Protara Therapeutics Inc [2024-04-09] 5.3
OrbiMed Advisors LLC Protara Therapeutics Inc [2022-02-11] 6.0
Rock Springs Capital Management LP Protara Therapeutics Inc [2020-10-02] 6.16
Perceptive Advisors LLC Protara Therapeutics Inc [2020-10-01] 5.8
Ikarian Capital LLC Artara Therapeutics Inc [2020-02-21] 5.3
Opaleye Management Inc Artara Therapeutics Inc [2020-01-21] 37.79
Wilson Donald R Jr Artara Therapeutics Inc [2020-01-16] 7.68
New Leaf Biopharma Opportunities II LP Proteon Therapeutics Inc [2018-11-06] 8.6
RA Capital Management LLC Proteon Therapeutics Inc [2018-02-14] 0.4
Flynn James E Proteon Therapeutics Inc [2017-06-29] 1.98
Intersouth Partners VI LP Proteon Therapeutics Inc [2015-04-07] 5.5
FMR LLC Proteon Therapeutics Inc [2015-02-13] 0.0
Pharmstandard International Sa Proteon Therapeutics Inc [2015-02-12] 7.1
Prism Venture Partners V L P Proteon Therapeutics Inc [2015-02-12] 7.6
MPM Bio IV NVS Strategic Fund LP Proteon Therapeutics Inc [2015-02-05] 6.0
TVM Life Science Ventures VI LP Proteon Therapeutics Inc [2014-11-04] 13.0
Skyline Venture Partners Qualified Purchaser Fund IV L P Proteon Therapeutics Inc [2014-11-03] 11.0
RA Capital Management LLC Proteon Therapeutics Inc [2014-10-31] 8.3
Abingworth LLP Proteon Therapeutics Inc [2014-10-31] 13.5
Flynn James E Proteon Therapeutics Inc [2014-10-27] 2.53
Form 3/4/5 Filer 2011 - 2025
Protara Therapeutics, Inc.
Shefferman Jesse
Sargen Gregory
Beshar Luke M
Flannelly Barry P
Garceau Roger
Huang Jane
Levy Richard S
Solomon Michael Edward
Smith Cynthia
Conkling William
Nicacio Leonardo Viana
Zummo Jacqueline
Fabbio Patrick
Fry Hannah
Opaleye Management Inc.
Bandari Jathin
Davis Blaine
Olivo Martin Sebastian
Marshall Randall
Braunstein Scott
Opaleye, L.P.
Casoy Julio
Abingworth LLP
Haines Timothy
Freund John Gordon
Burke Steven Keith
Noyes Timothy P
Toner E. Scott
Gottlieb Daniel Philip
Kowalsky Matthew Paul
Eldridge, George Arthur
Hartman Bradley J
Leff Jonathan S
Deerfield Management Company LP
Flynn James E
Canute Scott A
Birner Hubert
Bohlin Garen G
Kingsley Stuart A
Hastings Paul J
Deerfield Mgmt L.P.
Deerfield International Master Fund, L.P.
Deerfield Partners LP
Deerfield Private Design Fund IV, L.P.
Deerfield Mgmt III, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Mgmt IV, L.P.
Deerfield Private Design Fund III, L.P.
TVM Life Science Ventures VI GmbH & Co KG
Fischer Stefan
TVM Life Science Ventures VI LP
Schuhsler Helmut
O'Leary Brendan
Phelps Gregory D
Kobyzev Dmitry
Goll Alexandra
Skyline Venture Partners Qualified Purchaser Fund IV L P
Kaneko Yasunori
Skyline Venture Management IV, LLC
Joint Stock Co Pharmstandard
Pharmstandard International S.A.
Prism Venture Partners V-A LP
Prism Venture Partners V L P
Deerfield Special Situations International Master Fund, L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
Janus Henderson Group PLC [2025-06-30] DFND 0 4,102,620
BlackRock, Inc. [2025-06-30] SOLE 2,094,178 2,143,880
Velan Capital Investment Management LP [2025-06-30] SOLE 2,139,000 2,139,000
Blackstone Inc. [2025-06-30] OTR 0 1,909,662
Vanguard Group Inc [2025-06-30] SOLE 0 1,775,318
Acorn Capital Advisors LLC [2025-06-30] SOLE 1,752,115 1,752,115
Catalio Capital Management LP [2025-06-30] SOLE 1,626,370 1,626,370
Integral Health Asset Management LLC [2025-06-30] SOLE 1,400,000 1,400,000
Stempoint Capital LP [2025-06-30] SOLE 1,037,402 1,143,677
UBS Group AG [2025-06-30] DFND 1,135,567 1,135,767
RA Capital Management LP [2025-06-30] SOLE 1,039,295 1,039,295
Opaleye Management Inc [2025-06-30] SOLE 855,000 855,000
Woodline Partners LP [2025-06-30] SOLE 851,674 851,674
5AM Venture Management LLC [2025-06-30] SOLE 800,000 800,000
Geode Capital Management LLC [2025-06-30] DFND 744,519 744,519
Millennium Management LLC [2025-06-30] SOLE 564,120 564,120
Baker Bros Advisors LP [2025-06-30] SOLE 536,832 536,832
Citadel Advisors LLC [2025-06-30] DFND 433,731 433,731
Adage Capital Partners GP LLC [2025-06-30] SOLE 400,000 400,000
Marshall Wace LLP [2025-06-30] OTR 0 362,526
Superstring Capital Management LP [2025-06-30] SOLE 360,000 360,000
CIBC World Market Inc [2025-06-30] SOLE 291,494 291,494
State Street Corp [2025-06-30] DFND 258,707 290,907
Susquehanna International Group LLP [2025-06-30] OTR 219,897 259,797
Oppenheimer & Co Inc [2025-06-30] SOLE 246,064 246,064
Northern Trust Corp [2025-06-30] DFND 243,230 243,230
Bank of America Corp /DE/ [2025-06-30] DFND 0 181,600
Walleye Capital LLC [2025-06-30] SOLE 161,091 161,091
BNP Paribas Financial Markets [2025-06-30] DFND 0 154,665
Renaissance Technologies LLC [2025-06-30] SOLE 149,200 149,200
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com